Financial Health Report: Alignment Healthcare Inc (ALHC)’s Ratios Tell a Tale

In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Alignment Healthcare Inc (NASDAQ: ALHC) closed the day trading at $11.43 up 0.35% from the previous closing price of $11.39. In other words, the price has increased by $0.35 from its previous closing price. On the day, 1.9 million shares were traded. ALHC stock price reached its highest trading level at $11.66 during the session, while it also had its lowest trading level at $11.27.

Ratios:

For a better understanding of ALHC, let’s look at its different ratios. In the meantime, Its Debt-to-Equity ratio is 1.92 whereas as Long-Term Debt/Eq ratio is at 1.91.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Stephens on December 03, 2024, Upgraded its rating to Overweight and sets its target price to $17 from $13 previously.

BofA Securities Upgraded its Neutral to Buy on May 30, 2024, whereas the target price for the stock was revised from $7.75 to $11.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 05 ’24 when Kim Hyong sold 62,574 shares for $12.20 per share. The transaction valued at 763,572 led to the insider holds 470,496 shares of the business.

HYONG J KIM bought 62,574 shares of ALHC for $783,426 on Dec 05 ’24. On Nov 27 ’24, another insider, Kardes Hakan, who serves as the Chief Experience Officer of the company, sold 35,000 shares for $12.80 each. As a result, the insider received 448,140 and left with 320,444 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALHC now has a Market Capitalization of 2191085312 and an Enterprise Value of 2027543424. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.83 while its Price-to-Book (P/B) ratio in mrq is 19.12. Its current Enterprise Value per Revenue stands at 0.822 whereas that against EBITDA is -21.643.

Stock Price History:

Over the past 52 weeks, ALHC has reached a high of $14.25, while it has fallen to a 52-week low of $4.46. The 50-Day Moving Average of the stock is -3.94%, while the 200-Day Moving Average is calculated to be 32.50%.

Shares Statistics:

Over the past 3-months, ALHC traded about 1.87M shares per day on average, while over the past 10 days, ALHC traded about 1630110 shares per day. A total of 191.60M shares are outstanding, with a floating share count of 91.96M. Insiders hold about 52.03% of the company’s shares, while institutions hold 42.63% stake in the company. Shares short for ALHC as of 1731628800 were 3767974 with a Short Ratio of 2.01, compared to 1728950400 on 4422127. Therefore, it implies a Short% of Shares Outstanding of 3767974 and a Short% of Float of 3.0700000000000003.

Most Popular